2005
DOI: 10.1111/j.1540-9740.2005.03544.x
|View full text |Cite
|
Sign up to set email alerts
|

Lupus Miliaris Disseminatus Faciei Part II: An Overview

Abstract: Lupus miliaris disseminatus faciei, a chronic inflammatory disorder, is a controversial and enigmatic diagnostic/therapeutic entity. Multiple, discrete, smooth 1–3 mm brown/red or brown‐to‐yellowish dome‐shaped papules (sometimes with mild scaling) are its clinical characteristics. The lesions are usually located on the central and lateral side of the face. The condition is most often seen in young adults of both sexes, and diascopy may reveal apple‐jelly nodules. Lupus miliaris disseminatus faciei has clearly… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
15
0

Year Published

2013
2013
2022
2022

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 25 publications
(15 citation statements)
references
References 26 publications
0
15
0
Order By: Relevance
“…11,30 Other, noninfectious causes to consider include foreign body reactions, halogenodermas, lupus miliaris disseminatus faciei, necrobiosis lipoidica, superficial ulcerative rheumatoid necrobiosis, necrobiotic xanthogranuloma, annular elastolytic giant cell granuloma, metastatic Crohn disease, squamous cell carcinoma, lymphoproliferative disorders, and immunodeficiency disorders. 2,11,15,30,[41][42][43][44][45] The goals of treatment in cutaneous sarcoidosis are symptomatic relief, improvement of disease activity, and prevention of chronic disability. 37 Corticosteroids are the mainstay of treatment in ulcerative sarcoidosis, and methotrexate is a well-tolerated, steroid-sparing alternative.…”
Section: Discussionmentioning
confidence: 99%
“…11,30 Other, noninfectious causes to consider include foreign body reactions, halogenodermas, lupus miliaris disseminatus faciei, necrobiosis lipoidica, superficial ulcerative rheumatoid necrobiosis, necrobiotic xanthogranuloma, annular elastolytic giant cell granuloma, metastatic Crohn disease, squamous cell carcinoma, lymphoproliferative disorders, and immunodeficiency disorders. 2,11,15,30,[41][42][43][44][45] The goals of treatment in cutaneous sarcoidosis are symptomatic relief, improvement of disease activity, and prevention of chronic disability. 37 Corticosteroids are the mainstay of treatment in ulcerative sarcoidosis, and methotrexate is a well-tolerated, steroid-sparing alternative.…”
Section: Discussionmentioning
confidence: 99%
“…The latter entity is characterised by disseminated reddish-yellow papules usually on the central face, especially the periorbital and perioral area. 12 These manifestations significantly overlap with the ones of granulomatous rosacea, rendering the differential diagnosis particularly challenging. In fact, it remains controversial whether LMDF is a separate entity with 'rosacea-like' features or represents an 'extreme' type of granulomatous rosacea.…”
Section: Discussionmentioning
confidence: 99%
“…Lupus miliaris disseminatus faciei (LMDF) is a chronic cutaneous granulomatous disease characterized by multiple smooth reddish or yellowish papules on the central face, especially the lower eyelids and perioral area. [1][2][3] Owing to its clinical manifestations, LMDF has been considered as a variant of granulomatous rosacea (GA). 1,2 However, LMDF may be a distinct entity, different from GA, sarcoidosis, and cutaneous tuberculosis.…”
Section: Introductionmentioning
confidence: 99%
“…[1][2][3] Owing to its clinical manifestations, LMDF has been considered as a variant of granulomatous rosacea (GA). 1,2 However, LMDF may be a distinct entity, different from GA, sarcoidosis, and cutaneous tuberculosis. 1,2 Treatment of LMDF is usually challenging.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation